Skip to Main Content

Advertisement

Skip Nav Destination

Abstract CT032: CMP-001 demonstrates improved response in noninflamed anti-PD-1 refractory melanoma and response is associated with serum CXCL10

Cancer Res (2021) 81 (13_Supplement): CT032.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal